Disclosed is a novel photo-activatable derivative of ryanodine 9-hydroxy-21-(4-azidobenzoyloxy)-9-epiryanodine. This novel ryanodine derivative has been conjugated to keyhole limpet hemocyanin (KLH) and used for the production of antibodies with high affinity and specificity to ryanodine. A radioimmunoassay specific for ryanodine was developed using the anti-ryanodine antibodies, and a dissociation constant for ryanodine of 1 nM was determined. Also disclosed is the binding of a labeled, photoactivatable derivative of ryanodine (ABRy) with the ryanodine receptor of skeletal, cardiac and brain membranes. Digestion of the labeled ryanodine receptor revealed a labeled 76 kDa tryptic fragment which is critical for the formation of the high affinity ryanodine binding site.
Patent
Immunogenic ryanodine derivative and related uses
United States Patent and Trademark Office
02/20/1996
PDM V1.0, Open Access
Abstract
Details
- Title: Subtitle
- Immunogenic ryanodine derivative and related uses
- Creators
- Kevin P Campbell (Inventor)Derrick R Witcher (Inventor)Peter Mcpherson (Inventor)Steven D Kahl (Inventor)John D Windass (Inventor)Terence Lewis (Inventor)Philip Bentley (Inventor)
- Contributors
- University of Iowa Research Foundation (Iowa City, IA, US) (Assignee)
- Resource Type
- Patent
- Publisher
- United States Patent and Trademark Office; United States
- Patent
- US Patent 5,492,839; United States Patent and Trademark Office (United States, Alexandria) - USPTO; Published; 08/186,435; 01/25/1994
- Number of pages
- 20 pages
- Language
- English
- Date published
- 02/20/1996
- Academic Unit
- UI Research Foundation
- Record Identifier
- 9983762090002771
Metrics
7 File views/ downloads
24 Record Views